The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Nuromax     bis[3-[6,7,8-trimethoxy-2- methyl-1-[(3,4,5...

Synonyms: AGN-PC-00OIC1, AC1L1SOW, DB01135, DB01334, AC1Q66PG, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of C07549


High impact information on C07549


Chemical compound and disease context of C07549


Biological context of C07549


Anatomical context of C07549


Associations of C07549 with other chemical compounds


Gene context of C07549

  • The TOF ratio equaled 1 between 4.7 and 23.0 h, mean (SEM) 11.0 (2.1) h after termination of doxacurium infusion [16].

Analytical, diagnostic and therapeutic context of C07549


  1. Doxacurium. A review of its pharmacology and clinical potential in anaesthesia. Faulds, D., Clissold, S.P. Drugs (1991) [Pubmed]
  2. Hemodynamic effects of doxacurium chloride in patients receiving oxygen sufentanil anesthesia for coronary artery bypass grafting or valve replacement. Stoops, C.M., Curtis, C.A., Kovach, D.A., McCammon, R.L., Stoelting, R.K., Warren, T.M., Miller, D., Abou-Donia, M.M. Anesthesiology (1988) [Pubmed]
  3. Dose response, recovery, and cost of doxacurium as a continuous infusion in neurosurgical intensive care unit patients. Prielipp, R.C., Robinson, J.C., Wilson, J.A., MacGregor, D.A., Scuderi, P.E. Crit. Care Med. (1997) [Pubmed]
  4. Double-blind, randomized, multicenter study of doxacurium vs. pancuronium in intensive care unit patients who require neuromuscular-blocking agents. Murray, M.J., Coursin, D.B., Scuderi, P.E., Kamath, G., Prough, D.S., Howard, D.M., Abou-Donia, M.A. Crit. Care Med. (1995) [Pubmed]
  5. Neuromuscular block with doxacurium (BW A938U) in patients with normal or absent renal function. Cashman, J.N., Luke, J.J., Jones, R.M. British journal of anaesthesia. (1990) [Pubmed]
  6. Influence of aging on the pharmacokinetics and pharmacodynamics of doxacurium. Gariepy, L.P., Varin, F., Donati, F., Salib, Y., Bevan, D.R. Clin. Pharmacol. Ther. (1993) [Pubmed]
  7. Dose responses for neostigmine and edrophonium as antagonists of mivacurium in adults and children. Bevan, J.C., Tousignant, C., Stephenson, C., Blackman, L., Reimer, E., Smith, M.F., Bevan, D.R. Anesthesiology (1996) [Pubmed]
  8. The effects of succinylcholine on doxacurium-induced neuromuscular blockade. Katz, J.A., Fragen, R.J., Shanks, C.A., Dunn, K., McNulty, B., Rudd, G.D. Anesthesiology (1988) [Pubmed]
  9. Effects of doxacurium chloride on biventricular cardiac function in patients with cardiac disease. Reich, D.L., Konstadt, S.N., Thys, D.M., Hillel, Z., Raymond, R., Kaplan, J.A. British journal of anaesthesia. (1989) [Pubmed]
  10. Doxacurium and mivacurium do not trigger malignant hyperthermia in susceptible swine. Sufit, R.L., Kreul, J.F., Bellay, Y.M., Helmer, P., Brunson, D.B., Will, J. Anesth. Analg. (1990) [Pubmed]
  11. Clinical pharmacology of doxacurium chloride. A new long-acting nondepolarizing muscle relaxant. Basta, S.J., Savarese, J.J., Ali, H.H., Embree, P.B., Schwartz, A.F., Rudd, G.D., Wastila, W.B. Anesthesiology (1988) [Pubmed]
  12. The clinical pharmacology of doxacurium in young adults and in elderly patients. Martlew, R.A., Harper, N.J. Anaesthesia. (1995) [Pubmed]
  13. Pharmacokinetics and pharmacodynamics of doxacurium in young and elderly patients during isoflurane anesthesia. Dresner, D.L., Basta, S.J., Ali, H.H., Schwartz, A.F., Embree, P.B., Wargin, W.A., Lai, A.A., Brady, K.A., Savarese, J.J. Anesth. Analg. (1990) [Pubmed]
  14. Thyrotoxicosis factitia in a post-aortocoronary bypass patient. Redahan, C., Karski, J.M. Canadian journal of anaesthesia = Journal canadien d'anesthésie. (1994) [Pubmed]
  15. Cardiovascular effects of doxacurium, pancuronium and vecuronium in anaesthetized patients presenting for coronary artery bypass surgery. Emmott, R.S., Bracey, B.J., Goldhill, D.R., Yate, P.M., Flynn, P.J. British journal of anaesthesia. (1990) [Pubmed]
  16. Recovery from doxacurium infusion administered to produce immobility for more than four days in pediatric patients in the intensive care unit. Brandom, B.W., Yellon, R.F., Lloyd, M.E., Gronert, B.J., Theroux, M.C., Simhi, E., Chakravorti, S., Venkataraman, S., Dohar, J.E., Shapiro, A.M., Rimell, F.L., Reilly, J.S. Anesth. Analg. (1997) [Pubmed]
  17. Train-of-four recovery after pharmacologic antagonism of pancuronium-, pipecuronium-, and doxacurium-induced neuromuscular block in anaesthetized humans. Stinson, L.W., Lanier, W.L., Lennon, R.L. Acta anaesthesiologica Scandinavica. (1995) [Pubmed]
  18. Accelerated recovery from doxacurium-induced neuromuscular blockade in patients receiving chronic anticonvulsant therapy. Ornstein, E., Matteo, R.S., Weinstein, J.A., Halevy, J.D., Young, W.L., Abou-Donia, M.M. Journal of clinical anesthesia. (1991) [Pubmed]
  19. Population pharmacodynamics of doxacurium. Schmith, V.D., Fiedler-Kelly, J., Abou-Donia, M., Huffman, C.S., Grasela, T.H. Clin. Pharmacol. Ther. (1992) [Pubmed]
  20. The effects of neuromuscular paralysis on systemic and splanchnic oxygen utilization in mechanically ventilated patients. Marik, P.E., Kaufman, D. Chest (1996) [Pubmed]
WikiGenes - Universities